Class IIOngoingD-0012-2027
Drug recall · October 14, 2026
Biospectra Tris/Tromethamine recall
Why: Failed stability specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
- Lots / codes
Lot#: TRIS -E04-0226-0016; Exp 2/29/28
- Quantity
- 200 kg
- Company
- BioSpectra, Inc., Bangor, PA
- Distribution
- CA
- Initiated
- July 29, 2026 · Voluntary: Firm initiated
- Classified
- October 6, 2026
- Reported
- October 14, 2026
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tromethamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.